{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:39:12Z","timestamp":1762979952070,"version":"3.40.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Org Med Chem Lett"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Extracts from the marine algae <jats:italic>Cymopolia barbata<\/jats:italic> have previously shown promising pharmacological activity including antifungal, antitumor, antimicrobial, and antimutagenic properties. Even though extracts have demonstrated such bioactivity, isolated ingredients responsible for such bioactivity remain unspecified. In this study, we describe chemical characterization and evaluations of biological activity of prenylated bromohydroquinones (PBQ) isolated from the marine algae <jats:italic>C. barbata<\/jats:italic> for their cytotoxic and chemopreventive potential.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The impact of PBQs on the viability of cell lines (MCF-7, HT29, HepG, and CCD18 Co) was evaluated using the MTS assay. In addition, their inhibitory impact on the activities of heterologously expressed cytochrome P450 (CYP) enzymes (CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, and CYP3A4) was evaluated using a fluorescent assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>7-Hydroxycymopochromanone (PBQ1) and 7-hydroxycymopolone (PBQ2) were isolated using liquid and column chromatography, identified using <jats:sup>1<\/jats:sup>\u2009H and <jats:sup>13<\/jats:sup>\u2009C NMR spectra and compared with the spectra of previously isolated PBQs. PBQ2 selectively impacted the viability of HT29, colon cancer cells with similar potency to the known chemotherapeutic drug, fluorouracil (IC<jats:sub>50,<\/jats:sub> 19.82\u2009\u00b1\u20090.46 \u03bcM compared to 23.50\u2009\u00b1\u20091.12 \u03bcM, respectively) with impact toward normal colon cells also being comparable (55.65\u2009\u00b1\u20093.28 compared to 55.51\u2009\u00b1\u20093.71 \u03bcM, respectively), while PBQ1 had no impact on these cells. Both PBQs had potent inhibition against the activities of CYP1A1 and CYP1B1, the latter which is known to be a universal marker for cancer and a target for drug discovery. Inhibitors of CYP1 enzymes by virtue of the prevention of activation of carcinogens such as benzo-a-pyrene have drawn attention as potential chemopreventors. PBQ2 potently inhibited the activity of CYP1B1 (IC<jats:sub>50<\/jats:sub> 0.14\u2009\u00b1\u20090.04 \u03bcM), while both PBQ1 and PBQ2 potently inhibited the activity of CYP1A1 (IC<jats:sub>50<\/jats:sub>s of 0.39\u2009\u00b1\u20090.05 \u03bcM and 0.93\u2009\u00b1\u20090.26 \u03bcM, respectively). Further characterizations showed partial noncompetitive enzyme kinetics for PBQ2 with CYP1B1 with a <jats:italic>K<\/jats:italic>\n              <jats:sub>\n                <jats:italic>i<\/jats:italic>\n              <\/jats:sub> of 4.7 \u00d7 10<jats:sup>\u20133<\/jats:sup>\u2009\u00b1\u20095.1 \u00d7 10<jats:sup>\u20134<\/jats:sup> \u03bcM and uncompetitive kinetics with CYP1A1 (<jats:italic>K<\/jats:italic>\n              <jats:sub>\n                <jats:italic>i<\/jats:italic>\n              <\/jats:sub> = 0.84\u2009\u00b1\u20090.07 \u03bcM); while PBQ1 displayed partial non competitive enzyme kinetics with CYP1A1 (<jats:italic>K<\/jats:italic>\n              <jats:sub>\n                <jats:italic>i<\/jats:italic>\n              <\/jats:sub> of 3.07\u2009\u00b1\u20090.69 \u03bcM), noncompetitive kinetics with CYP1A2 (<jats:italic>K<\/jats:italic>\n              <jats:sub>\n                <jats:italic>i<\/jats:italic>\n              <\/jats:sub>\u2009<jats:italic>=<\/jats:italic>\u20099.16\u2009\u00b1\u20094.68 \u03bcM) and uncompetitive kinetics with CYP1B1 (<jats:italic>K<\/jats:italic>\n              <jats:sub>\n                <jats:italic>i<\/jats:italic>\n              <\/jats:sub> = 0.26\u2009\u00b1\u20090.03 \u03bcM) .<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We report for the first time, two isolated ingredients from <jats:italic>C. barbata<\/jats:italic>, PBQ1 and PBQ2, that show potential as valuable chemotherapeutic compounds. A hydroxyl moiety resident in PBQ2 appears to be critical for selectivity and potency against the cancer colon cells, HT29, in comparison to the three other malignant cell lines studied. PBQs also show potency against the activities of CYP1 enzyme which may be a lead in chemoprevention. This study, the first on isolates from these marine algae, exemplifies the value of searching within nature for unique structural motifs that can display multiple biological activities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/2191-2858-2-21","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T16:23:06Z","timestamp":1357748586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cytotoxic and potent CYP1 inhibitors from the marine algae Cymopolia barbata"],"prefix":"10.1186","volume":"2","author":[{"given":"Simone","family":"Badal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winklet","family":"Gallimore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzuen-Rong Jeremy","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupika","family":"Delgoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,11]]},"reference":[{"key":"47_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1021\/np010418q","volume":"65","author":"E Dorta","year":"2002","unstructured":"Dorta E, Darias J, Martin AS, Cueto M: New Prenylated bromoquinols from the green alga Cymopolia barbata. J Nat Prod 2002, 65: 329\u2013333. 10.1021\/np010418q","journal-title":"J Nat Prod"},{"key":"47_CR2","first-page":"1696","volume":"1","author":"HE H\u00f6gberg","year":"1976","unstructured":"H\u00f6gberg HE, Thomson RH, King TJ: The cymopols, a group of prenylated bromohydroquinones from the green calcareous alga Cympolia barbata. J Chem Soc 1976, 1: 1696\u20131701.","journal-title":"J Chem Soc"},{"key":"47_CR3","first-page":"131","volume":"10","author":"NG Mart\u00ednez-Nadal","year":"1964","unstructured":"Mart\u00ednez-Nadal NG, Rodr\u00edguez LV, Casillas S: Isolation and characterization of sarganin complex, a new broad spectrum antibiotic isolated from marine algae. Antimicrob Agents Chemother 1964, 10: 131.","journal-title":"Antimicrob Agents Chemother"},{"key":"47_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1021\/np50052a028","volume":"50","author":"DM Estrada","year":"1987","unstructured":"Estrada DM, Mart\u00edn JD, P\u00e9rez CA: New Brominated monoterpenoid quinol from Cymopolia barbata. J Nat Prod 1987, 50: 735\u2013737. 10.1021\/np50052a028","journal-title":"J Nat Prod"},{"key":"47_CR5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1021\/np50065a028","volume":"52","author":"EM Wall","year":"1989","unstructured":"Wall EM, Wani MC, Manikumar G, Taylor H, Hughes TJ, Gerwick WH, McPhail AT, McPhail DR: Plant antimutagenic agents 7. Structure and antimutagenic properties of cymobarbatol and 4-isocymbarbatol, new cymopols from green alga (Cymopolia barbata). J Nat Prod 1989, 52: 1092\u20131099. 10.1021\/np50065a028","journal-title":"J Nat Prod"},{"key":"47_CR6","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/BF00989101","volume":"8","author":"OJ McConnell","year":"1982","unstructured":"McConnell OJ, Hughes PA, Targett NM, Daley J: Effects of secondary metabolites from marine algae on feeding by the sea urchin. Lytechinus variegatus. J Chem Ecol 1982, 8: 1427.","journal-title":"J Chem Ecol"},{"key":"47_CR7","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1016\/0031-9422(92)80424-D","volume":"31","author":"M Park","year":"1992","unstructured":"Park M, Fenical W, Hay M: Debromoisocymobarbatol, a new chromanol feeding deterrent from the marine alga Cymopolia barbata. Phytochemistry 1992, 31: 4115\u20134118. 10.1016\/0031-9422(92)80424-D","journal-title":"Phytochemistry"},{"key":"47_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00984009","volume":"8","author":"NM Targett","year":"1989","unstructured":"Targett NM, McConnell OJ: Detection of secondary metabolites in marine macroalgae using the marsh periwinkle, Littorina irrorata say, as an indicator organism. J Chem Ecol 1989, 8: 115.","journal-title":"J Chem Ecol"},{"key":"47_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1124\/dmd.109.031351","volume":"38","author":"HI Swanson","year":"2010","unstructured":"Swanson HI, Njar VCO, Yu Z, Castro DJ, Gonzalez FJ, Williams DE, Huang Y, Kong AT, Doloff JC, Ma J, Waxman DJ, Scott EE: Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy. Drug Metab Dispos 2010, 38: 539\u2013544. 10.1124\/dmd.109.031351","journal-title":"Drug Metab Dispos"},{"key":"47_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1158\/1940-6207.CAPR-07-0004","volume":"1","author":"DJ Castro","year":"2008","unstructured":"Castro DJ, Baird WM, Pereira CB, Giovanni J, L\u00f6hr C, Fischer K, Yu Z, Gonzalez FJ, Krueger SK, Williams DE: Fetal mouse cyp1b1 and transplacental carcinogenesis from maternal exposure to Dibenzo[a, l]pyrene. Cancer Prev Res 2008, 1: 128\u2013134. 10.1158\/1940-6207.CAPR-07-0004","journal-title":"Cancer Prev Res"},{"key":"47_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.2004.tb03162.x","volume":"95","author":"T Shimada","year":"2004","unstructured":"Shimada T, Fujii-Kuriyama Y: Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochrome P50 1A1 and 1B1. Cancer Sci 2004, 95: 1\u20136. 10.1111\/j.1349-7006.2004.tb03162.x","journal-title":"Cancer Sci"},{"key":"47_CR12","first-page":"1179","volume":"29","author":"T Shimada","year":"2001","unstructured":"Shimada T, Oda Y, Gillam EMJ, Guengerich FP, Inoue K: Metabolic activation of polycyclic aromatic hydrocarbons and their dihydridiol derivation and other procarcinogens by cytochrome P450 1A1 and 1B1 allelic variants and other human cytochrome P450 enzymes in Salmonella typhimurium NM2009. Drug Metab Dispos 2001, 29: 1179\u20131182.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"47_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/jbt.20259","volume":"23","author":"K Skupinska","year":"2009","unstructured":"Skupinska K, Misiewicz-Krzeminska I, Stypulkowski R, Lubelska K, Kasprzycka-Guttman T: Sulforaphane and its analogues inhibit CYP1A1 and CYP1A2 activity induced by benzo[a]pyrene. J Biochem Mol Toxicol 2009,23(1):18\u201328. 10.1002\/jbt.20259","journal-title":"J Biochem Mol Toxicol"},{"key":"47_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/(SICI)1097-0320(19970101)27:1<26::AID-CYTO4>3.0.CO;2-J","volume":"27","author":"J Palmari","year":"1996","unstructured":"Palmari J, Dussert C, Berthois Y, Penel C, Martin PM: Distribution of estrogen receptor heterogeneity in growing MCF-7 cells measured by quantitative microscopy. Cytometry 1996, 27: 26\u201335.","journal-title":"Cytometry"},{"key":"47_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0304-3835(98)00335-8","volume":"136","author":"WL Heusch","year":"1999","unstructured":"Heusch WL, Maneckjee R: Effects of bombesin on methadone-induced apoptosis of human lung cancer cells. Cancer Lett 1999, 136: 177\u2013185. 10.1016\/S0304-3835(98)00335-8","journal-title":"Cancer Lett"},{"key":"47_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1006\/abio.1997.2145","volume":"48","author":"CL Crespi","year":"1997","unstructured":"Crespi CL, Miller VP, Penman BW: Microtitre plate assays for inhibition of human, drug metabolising cytochromes P450. Anal Biochem 1997, 48: 188\u2013190.","journal-title":"Anal Biochem"},{"key":"47_CR17","volume-title":"High-throughput inhibition screening of five major human cytochrome P450 enzymes using an in vitro substrate cocktail","author":"RH Powrie","year":"2007","unstructured":"Powrie RH: High-throughput inhibition screening of five major human cytochrome P450 enzymes using an in vitro substrate cocktail. 2007."},{"key":"47_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/dmd.32.1.105","volume":"32","author":"DM Stresser","year":"2004","unstructured":"Stresser DM, Broudy MI, Ho T, Cargil CE, Blnachard AP, Sharma R, Dandeneau AA, Goodwin JJ, Turner SD, Erve JCL, Patten CJ, Dehal SS, Crespi CL: Highly selective inhibition of human CYP3A in vitro by azmulin and evidence that inhibition is irreversible. Drug Metab Dispos 2004, 32: 105\u2013112. 10.1124\/dmd.32.1.105","journal-title":"Drug Metab Dispos"},{"key":"47_CR19","volume-title":"Cell Notes Issue","author":"J Cali","year":"2003","unstructured":"Cali J: Screen for CYP450 inhibitors using P450-GLOTM luminescent cytochrome P450 assays. Cell Notes Issue 2003. Available at www.promega.com"},{"key":"47_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1124\/dmd.32.6.584","volume":"32","author":"X Cai","year":"2004","unstructured":"Cai X, Wang RW, Edom RW, Evans DC, Shou M, Rodrigues D, Liu W, Dean DC, Baillie TA: Validation of (\u2212)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomes. Drug Metab Dispos 2004, 32: 584\u2013586. 10.1124\/dmd.32.6.584","journal-title":"Drug Metab Dispos"},{"key":"47_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.fitote.2010.10.003","volume":"82","author":"S Badal","year":"2011","unstructured":"Badal S, Williams SA, Huang G, Francis S, Vendantam P, Dunbar O, Jacobs H, Tzeng TJ, Gangemi J, Delgoda R: Cytochrome P450 1 enzyme inhibition and anticancer potential of chromene amides from Amyris plumieri. Fitoterapia 2011, 82: 230\u2013236. 10.1016\/j.fitote.2010.10.003","journal-title":"Fitoterapia"},{"key":"47_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0027-5107(02)00332-9","volume":"523\u2013524","author":"C Gerhauser","year":"2003","unstructured":"Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, Liu GY, Sitthimunchai S, Frank N: Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res 2003, 523\u2013524: 163\u2013172.","journal-title":"Mutat Res"},{"key":"47_CR23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.tiv.2007.04.005","volume":"21","author":"H Leung","year":"2007","unstructured":"Leung H, Wang Y, Chan H, Leung L: Developing a high throughput system for the screening of cytochrome P450 1A1\u2014inhibitory polyphenols. Toxicol In Vitro 2007, 21: 996\u20131002. 10.1016\/j.tiv.2007.04.005","journal-title":"Toxicol In Vitro"},{"key":"47_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/med.10033","volume":"3","author":"W Ren","year":"2003","unstructured":"Ren W, Qiao Z, Wang H, Zhu L, Zhang L: Flavonoids: promising anticancer agents. Med Res Rev 2003, 3: 519\u2013534.","journal-title":"Med Res Rev"},{"key":"47_CR25","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-05-0152","volume":"4","author":"D Xiao","year":"2005","unstructured":"Xiao D, Pinto JT, Gundersen GG, Weinstein IB: Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol Cancer Ther 2005, 4: 1388\u20131398. 10.1158\/1535-7163.MCT-05-0152","journal-title":"Mol Cancer Ther"},{"key":"47_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/carcin\/22.8.1111","volume":"22","author":"J Gusman","year":"2001","unstructured":"Gusman J, Malonne H, Atassi G: A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 2001, 22: 1111\u20131117. 10.1093\/carcin\/22.8.1111","journal-title":"Carcinogenesis"},{"key":"47_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ijrobp.2003.09.064","volume":"58","author":"DM Carnell","year":"2004","unstructured":"Carnell DM, Smith RE, Daley FM, Barber PR, Hoskin PJ, Wilson GD, Murraly GI, Everett SA: Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. Int J Radiat Oncol Biol Phys 2004, 58: 500\u2013509. 10.1016\/j.ijrobp.2003.09.064","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"47_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00432-008-0483-2","volume":"135","author":"A Prawan","year":"2009","unstructured":"Prawan A, Buranrat B, Kukongviriyapan U, Sripa B, Kukongviriyapan V: Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells. J Cancer Res Clin Oncol 2009, 135: 515\u2013522. 10.1007\/s00432-008-0483-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"47_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tox.2005.09.010","volume":"217","author":"A Chaudhary","year":"2006","unstructured":"Chaudhary A, Willet KL: Inhibition of human cytochrome CYP1 enzymes by flavonoids of St John\u2019s wort. Toxicology 2006, 217: 194\u2013205. 10.1016\/j.tox.2005.09.010","journal-title":"Toxicology"},{"key":"47_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0753-3322(02)00186-5","volume":"58","author":"LL Marchand","year":"2002","unstructured":"Marchand LL: Cancer preventive effects of flavonoids\u2014a review. Biomed Pharmacother 2002, 58: 296\u2013301.","journal-title":"Biomed Pharmacother"},{"key":"47_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1389200054021834","volume":"6","author":"ZY Zhang","year":"2005","unstructured":"Zhang ZY, Wong YN: Enzyme kinetics for clinically relevant CYP inhibition. Curr Drug Metab 2005, 6: 241\u2013257. 10.2174\/1389200054021834","journal-title":"Curr Drug Metab"},{"key":"47_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-0028-1088350","volume":"75","author":"M Shields","year":"2009","unstructured":"Shields M, Niazi U, Badal S, Yee T, Sutcliffe M, Delgoda R: Inhibition of CYP1A1 by quassinoids found in Picrasma excelsa. Planta Medica 2009, 75: 137\u2013141. 10.1055\/s-0028-1088350","journal-title":"Planta Medica"},{"issue":"9\u201310","key":"47_CR33","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/sj.bjc.6690216","volume":"79","author":"H Ciolino","year":"1999","unstructured":"Ciolino H, Yeh G: The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist\/antagonist of the aryl hydrocarbon receptor. Br J Cancer 1999,79(9\u201310):1340\u20131346.","journal-title":"Br J Cancer"},{"key":"47_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3184\/030823409X416901","volume":"3","author":"WW Gallimore","year":"2009","unstructured":"Gallimore WW, Sambo T, Campbell T: Debromocymopolone from the green alga, Cymopolia barbata. J Chem Res 2009, 3: 160\u2013161.","journal-title":"J Chem Res"}],"container-title":["Organic and Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2191-2858-2-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:31:41Z","timestamp":1630531901000},"score":1,"resource":{"primary":{"URL":"https:\/\/orgmedchemlett.springeropen.com\/articles\/10.1186\/2191-2858-2-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1186\/2191-2858-2-21","relation":{},"ISSN":["2191-2858"],"issn-type":[{"type":"electronic","value":"2191-2858"}],"subject":[],"published":{"date-parts":[[2012,6,11]]},"assertion":[{"value":"6 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}